Company Biodel Inc Nasdaq
Equities
US09064M1053
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | CAC40: in green, gains over 2% on a weekly basis | CF |
2023 | CAC40: PMI and ISM data point to 22nd week of gains | CF |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 03-12-07 | |
President | 57 | 23-03-01 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-12 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-12-18 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 23-03-01 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 19-11-03 |
Muffy Carter
LAW | General Counsel | 71 | 16-11-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 23-03-01 | |
Director/Board Member | 62 | 23-03-01 | |
Alan Sokaler
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,709,043 | 18,650,831 ( 90.06 %) | 7,760 ( 0.0375 %) | 90.06 % |
Company contact information
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sector
1st Jan change | Capi. | |
---|---|---|
+16.13% | 122B | |
+19.65% | 113B | |
+18.22% | 26.49B | |
-23.84% | 19.4B | |
-18.84% | 16.24B | |
-19.28% | 15.4B | |
-45.95% | 15.15B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- ALBO Stock
- Stock
- Company Biodel Inc